TANGO THERAPEUTICS INC. - COMMON STOCK

Tango Therapeutics to Participate in the Jefferies London Healthcare Conference

11 11 2021 07:00:01 提供 Nasdaq GlobeNewswire

Tango Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Highlights

09 11 2021 07:00:02 提供 Nasdaq GlobeNewswire

Tango Therapeutics Announces Appointment of Dr. Marc Rudoltz as Chief Medical Officer and Doug Barry as General Counsel

01 11 2021 07:00:00 提供 Nasdaq GlobeNewswire

Tango Therapeutics Debuts as Publicly Traded Precision Oncology Company Focused on the Next Generation of Targeted Cancer Therapies

10 8 2021 09:00:01 提供 Nasdaq GlobeNewswire